This innovative therapy is indicated for prevention of serious lower respiratory tract disease requiring hospitalisation caused by Respiratory Syncytial Virus (RSV) in children at high risk of RSV disease, it added.
Enhance Your Healthcare Expertise with High-Impact Courses
Offering College | Course | Website |
---|---|---|
IIM Kozhikode | IIMK Healthcare Management & Analytics Programme | Visit |
Indian School of Business | ISB Healthcare Management | Visit |
RSV is a public health challenge faced across the globe today and is the second most common cause of death in children under 1 year of age.
The disease is responsible for nearly 50 per cent of pneumonia cases and up to 90 per cent of bronchiolitis cases among infants.